Compare trial results at 24 months of two different minimally invasive glaucoma surgeries— the Hydrus™ and the iStent® without cataract surgery being performed at the same time.
Iqbal Ike K. Ahmed, MD, FRCSC, asks surgeons to comment on what excites them about the future of minimally invasive glaucoma surgery (MIGS). Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; and David Richardson, MD, discuss MIGS devices in the pipeline and explain how these procedures improve the quality of life for both patients and physicians.
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.
Iqbal Ike K. Ahmed, MD, FRCSC, opens up discussion on preferred minimally invasive glaucoma surgery (MIGS) procedures. Mark J. Gallardo, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and Nathan M. Radcliffe, MD, each describe their approach to MIGS and discuss the mechanism of action of ABiC iTrack (Ellex).
Iqbal Ike K. Ahmed, MD, FRCSC, Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; Mark J. Gallardo, MD; and David Richardson, MD, discuss the the misconceptions surrounding selective laser trabeculoplasty (SLT), safety and efficacy of SLT and highlight the advantages of minimizing the medication burden for patients.
At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of open angle glaucoma (OAG).
